Develop, manufacture, and sell genomic analysis oncology diagnostics
Food and Drug Administration regulatory policy generally and policy for approval of new oncology diagnostic technologies
Drug pricing reforms generally
S. 1895 (Lower Health Care Costs Act), Section 401, regarding hospital billing practices
H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices
H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions
Reimbursement for new oncology diagnostic technologies generally, including public and private payers Medicare program policy for regulatory approval and reimbursement for new oncology diagnostic technologies 
Reimbursement for new oncology diagnostic technologies generally
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ARENTFOX SCHIFF LLP
1717 K Street, NW, Washington, DC, 20006, US
DAN RENBERG DAN RENBERG